Naperville, IL -- (SBWIRE) -- 04/13/2015 -- Reportstack, provider of premium market research reports announces the addition of EUROPEAN MARKETS FOR SOFT TISSUE REINFORCEMENT AND REGENERATION market report to its offering
The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.
American Medical Systems
Lowmann & Rauscher
Smith & Nephew
Complete report is available